Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sheng-bin Shi"'
Publikováno v:
Oncotarget
// Cui-Juan Wang 1, 3, * , Sheng-Bin Shi 2, * , Jing Tian 2 , Jun Xu 2 and Zuo-Xing Niu 2 1 Shandong University of Traditional Chinese Medicine, Jinan, P.R. China 2 Department of Medical Oncology, Shandong Cancer Hospital Affiliated to Shandong Unive
Publikováno v:
2019 12th International Conference on Intelligent Computation Technology and Automation (ICICTA).
In order to improve the speed and accuracy of target tracking for missile-borne image, a method for detection, tracking and segmentation based on IoU correlation is proposed. By designing the anchor boxes on the multi-scale prediction branch, an enha
Publikováno v:
Oncology Research
We evaluated the efficacy and feasibility of the combination of gemcitabine plus vinorelbine in patients with platinum-based chemotherapy-refractory esophageal cancer. We enrolled 35 patients who received gemcitabine plus vinorelbine as second-line t
Publikováno v:
Tetrahedron Letters. 61:151655
Two unusual monoterpene racemates, (±)-eupafortin A (1) and (±)-eupafortin B (2), were isolated from the aerial parts of Eupatorium fortunei. Subsequent chiral resolution led to the separation of two pairs of enantiomers, (+)- (1a) and (–)-eupafo
Publikováno v:
Pancreatology. 12:475-479
To evaluate the efficacy and tolerability of capecitabine combined with thalidomide in patients with advanced pancreatic cancer (APC) who have previously received gemcitabine-based therapy.A total of 31 patients were recruited prospectively in Shando
Publikováno v:
OncoTargets and therapy
Bin Zhang,1,* Rui Li,2,3,* Chun-Xiao Chang,2,3 Yong Han,2,3 Sheng-Bin Shi,2,3 Jing Tian2,3 1Department of Medical Oncology, Shandong Ji Ning First People’s Hospital, 2Department of Medical Oncology, Shandong Cancer Hospital, Shandong University, Sh
Publikováno v:
Tumori Journal. 98:314-319
Aims and background The incidence and development of cancer are closely related to dysfunction of immune function. The immune system cannot identify and remove malignant and mutant cells, which cause tumor cells to escape from surveillance and cleara
Publikováno v:
Translational research : the journal of laboratory and clinical medicine. 170
This study was conducted to evaluate microRNAs (miRNAs) as biomarkers for use in predicting the efficacy of maintenance therapy with pemetrexed in patients with stage IIIb or IV lung adenocarcinoma and who had already received first-line treatment wi
Publikováno v:
Cancer chemotherapy and pharmacology. 76(4)
The aim of this study was to evaluate the efficacy and toxicity of cetuximab and pemetrexed as the second-line treatment for advanced esophageal cancer patients, who had undergone treatment with the standard cisplatin and 5-FU regimens.A total of 29
Publikováno v:
Medical oncology (Northwood, London, England). 32(1)
The aim of the study was to determine the efficacy and toxicity of pemetrexed plus rituximab in patients with primary central nervous system lymphoma, who had undergone treatment with high-dose (HD) methotrexate-based regimens. Patients who had faile